Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR

Parasitology Research

Volumn 98, Issue 6, 2006, Pages 511-518

  Flori, Pierre ^a,b   Tardy, Laëtitia ^b   Jacquet, Alain ^c   Bellete, Bahrie ^b   Hafid, Jamal ^d   Raberin, Hélène ^b   Tran Manh Sung, Roger ^b  

^a HÔPITAL NORD   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c Service de Génétique Appliquée   (Belgium)

^d FACULTÉ DES SCIENCES ET TECHNIQUES GUÉLIZ   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; PARASITE ANTIGEN; RECOMBINANT PROTEIN; RECOMBINANT SAG 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY BURDEN; BRAIN; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GUINEA PIG; IMMUNIZATION; IMMUNOREACTIVITY; LUNG; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SEROLOGY; STRAIN DIFFERENCE; TISSUE LEVEL; TOXOPLASMA GONDII 76K; TOXOPLASMA GONDII C56; TOXOPLASMOSIS;

ANIMALIA; CAVIA; CAVIA PORCELLUS; TOXOPLASMA GONDII;

EID: 33645459970     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-005-0074-y     Document Type: Article

References (33)

1. Ambroise-Thomas P, Garin JP, Rigaud A (1966) Amélioration de la technique d'immuno-fluorescence par l'emploi de contre-colorants. Application aux toxoplasmes. Presse Med 74:2215-2216
2. Angus CW, Klivington-Evans D, Dubey JP, Kovacs JA (2000) Immunisation with a DNA plasmid encoding the SAG1 (P30) protein of T. gondii is immunogenic and protective in rodents. J Infect Dis 181:317-324
3. Azjenberg D, Banuls AL, Tibayrenc M, Darde ML (2002) Microsatellite analysis of T. gondii shows considerable polymorphism structured into two main clonal groups. Int J Parasitol 32:27-38
4. Bellete B, Flori P, Hafid J, Raberin H, Tran Manh Sung R (2003) Influence of the quantity of nonspecific DNA and repeated freezing and thawing of samples on the quantification of DNA by the Light Cycler. J Microbiol Methods 55:213-219
5. Biemans R, Gregoire D, Haumont M, Bosseloir A, Garcia L, Jacquet A, Dubeaux C, Bollen A (1998) The conformation of purified T. gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. J Biotechnol 66:137-146
6. Bonenfant C, Dimier-Poisson I, Velge-Roussel F, Buzoni-Gatel D, Del Giudice G, Rappuoli R, Bout D (2001) Intranasal immunisation with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against T. gondii. Infect Immun 69:1605-1612
7. Bout DT, Mevelec MN, Velge-Roussel F, Dimier-Poisson I, Lebrun M (2002) Prospects for a human Toxoplasma vaccine. Curr Drug Targets Immune Endocr Metabol Disord 2:227-234
8. Burggraf S, Olgemoller B (2004) Simple technique for internal control of real-time amplification assays. Clin Chem 50:819-825
9. Chen G, Chen H, Guo H, Zheng H (2002) Protective effect of DNA-mediated immunisation with a combination of SAG1 and IL-2 gene adjuvant against infection of T. gondii in mice. Chin Med J 115:1448-1452
10. Couper KN, Nielsen HV, Petersen E, Roberts F, Roberts CW, Alexander J (2003) DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired T. gondii infection but does not prevent maternofoetal transmission. Vaccine 21:2813-2820
11. Darde ML (2005) "Virulence" of Toxoplasma strains in humans. In: 15th European congress of clinical microbiology and infectious diseases, Copenhagen
12. Debard N, Buzoni-Gatel D, Bout D (1996) Intranasal immunisation with SAG1 protein of T. gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect Immun 64:2158-2166
13. Fachado A, Rodriguez A, Angel SO, Pinto DC, Vila I, Acosta A, Amendoeira RR, Lannes-Vieira J (2003) Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21:1327-1335
14. Flori P, Hafid J, Bourlet T, Raberin H, Genin C, Tran Manh Sung R (2002) Experimental model of congenital toxoplasmosis in guinea-pigs: use of quantitative and qualitative PCR for the study of maternofetal transmission. J Med Microbiol 51:871-878
15. Flori P, Hafid J, Thonier V, Bellete B, Raberin H, Tran Manh Sung R (2003) Parasite load in guinea pig foetus with real-time PCR after maternofoetal transmission of T. gondii. Parasite 10:133-140
16. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, Villena I, Jenum PA, Hayde M, Naessens A (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180:410-415
17. Haumont M, Delhaye L, Garcia L, Jurado M, Mazzu P, Daminet V, Verlant V, Bollen A, Biemans R, Jacquet A (2000) Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect Immun 68:4948-4953
18. Kasper LH, Currie KM, Bradley MS (1985) An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii. J Immunol 134:3426-3431
19. Letscher-Bru V, Villard O, Risse B, Zauke M, Klein JP, Kien TT (1998) Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect Immun 66:4503-4506
20. Letscher-Bru V, Pfaff AW, Abou-Bacar A, Filisetti D, Antoni E, Villard O, Klein JP, Candolfi E (2003) Vaccination with T. gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun 71:6615-6619
21. Leyva R, Herion P, Saavedra R (2001) Genetic immunisation with plasmid DNA coding for the ROP2 protein of T. gondii. Parasitol Res 87:70-79
22. Lyons RE, McLeod R, Roberts CW (2002) T. gondii tachyzoitebradyzoite interconversion. Trends Parasitol 18:198-201
23. Manger ID, Hehl AB, Boothroyd, JC (1998) The surface of Toxoplasma tachyzoites is dominated by a family of glycosylphosphatidyl-inositol-anchored antigens related to SAG1. Infect Immun 66:2237-2244
24. Martin V, Supanitsky A, Echeverria PC, Litwin S, Tanos T, De Roodt AR, Guarnera EA, Angel SO (2004) Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol 11:704-710
25. Menotti J, Vilela G, Romand S, Garin YJ, Ades L, Gluckman E, Derouin F, Ribaud P (2003) Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient. J Clin Microbiol 41:5313-5316
26. Mevelec MN, Bout D, Desolme B, Marchand H, Magne R, Bruneel O, Buzoni-Gatel D (2005) Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23:4489-4499
27. Mohamed RM, Aosai F, Chen M, Mun HS, Norose K, Belal US, Piao LX, Yano A (2003) Induction of protective immunity by DNA vaccination with T. gondii HSP70, HSP30 and SAG1 genes. Vaccine 21:2852-2861
28. Nielsen HV, Lauemoller SL, Christiansen L, Buus S, Fomsgaard A, Petersen E (1999) Complete protection against lethal T. gondii infection in mice immunised with a plasmid encoding the SAG1 gene. Infect Immun 67:6358-6363
29. Petersen E, Nielsen HV, Christiansen L, Spenter J (1998) Immunisation with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with T. gondii. Vaccine 16:1283-1289
30. Reischl U, Bretagne S, Kruger D, Ernault P, Costa JM (2003) Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 3:7
31. Vercammen M, Scorza T, Huygen K, De Braekeleer J, Diet R, Jacobs D, Saman E, Verschueren H (2000) DNA vaccination with genes encoding T. gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 68:38-45
32. Yang CD, Chang GN, Chao D (2004) Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2. Parasitol Res 92:58-64
33. Zenner L, Estaquier J, Darcy F, Maes P, Capron A, Cesbron-Delauw MF (1999) Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite Immunol 21:261-272